Amedisys Fair Value
AM
The fair market value of AMED stock is 89.71 USD. Relative to the market price of 91 USD Amedisys is overvalued by 1.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Amedisys Valuation
Current AMED share ticker price is 91 USD.
The fair value level of 89.71 USD can be considered as an effective entry point for long-term investors to start investing in AMED stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 1% higher its fair value
Current price is 36% higher its minimum value
Current price is 46% lower its maximum value
Market price:
AMED stock is overvalued
It means the current price may concern as a Risky Entry Point
Amedisys Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
52.39
2
Median P/E over 5 years
35.35
3
Minimum P/E over 5 years
22.89
4
Earning per share (last 12 months)
2.54 USD
Maximum value
1
x
4
=
132.96 USD
Fair value
2
x
4
=
89.71 USD
Minimum value
3
x
4
=
58.08 USD
Amedisys Inc price metrics
-8.5
Annual return (geometric mean)
39.8
Risk (standard deviation) of returns
β
0.75
Beta (volatility compared to market)